US Patent 11903934 Rifabutin treatment methods, uses, and compositions
Patent 11903934 was granted and assigned to BioVersys AG on February, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11903934 Rifabutin treatment methods, uses, and compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.